A randomized controlled trial of lamivudine in acute hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Jan 2007 Results have been published.
- 17 Nov 2006 New trial record.